Nasdaq ETFs

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Weyerhaeuser Co (Symbol: WY) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.2% yield, as well as being recognized by prominent asset managers as being a sociall

Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $22.5B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 2.89% yield, according to the most recent Dividend Channel '

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

In recent trading, shares of Xcel Energy Inc (Symbol: XEL) have crossed above the average analyst 12-month target price of $70.36, changing hands for $71.59/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

In recent trading, shares of Visteon Corp (Symbol: VC) have crossed above the average analyst 12-month target price of $137.54, changing hands for $142.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

In recent trading, shares of Horizon Therapeutics plc (Symbol: HZNP) have crossed above the average analyst 12-month target price of $111.20, changing hands for $112.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr

Been on social media lately? You’ve probably seen at least one example of the AI photo trend in which people submit images of themselves to the image generator Lensa, from Prisma Labs, and then post several depictions of themselves in different artistic styles. Investors keeping an eye on the popular app may want to watch [...] Read more at ETFtrends.com.

Factor investing can make it possible to target specific market attributes, which may help mitigate risk, particularly in unsteady markets. In the upcoming webcast, Can Factor-Based Strategies Help Mitigate Volatility?, Craig Lazzara, managing director and core product management at S&P Dow Jones Indices; Nick Kalivas, head of factor and core equity product strategy at Invesco; [...] Read more at ETFtrends.com.

Tom Lydon appeared on the CNBC Halftime Report and ETF Edge earlier today, with Dominic Chu filling in for regular host Bob Pisani. Lydon was joined on ETF Edge by GraniteShares founder and CEO Will Rhind to discuss the flows into China ETFs and other hot ETF topics. China ETFs See Flows With ETFs such [...] Read more at ETFtrends.com.

As we consider the outlook for the gold market, exchange traded fund investors should take a look at the role of the asset class in a diversified portfolio, with a particular emphasis on gold royalty companies. In the recent webcast, Could Gold Be Poised for a Comeback In 2023?, Frank Holmes, CEO and chief investment [...] Read more at ETFtrends.com.

With the year drawing to a close, investors can take the opportunity to reflect on the ETF world and the trends that defined the year. The growth of active ETFs continued in 2022 as one of the major themes for the year, and despite the wild geopolitical, inflationary, and interest rate risks, several active equity [...] Read more at ETFtrends.com.

Carbon allowances prices in Europe have been on an upward trend in December, rising more than 20% in the last two weeks, buoyed by the upcoming end of year auction, expiration of options and futures contracts, and the arrival of colder weather in Europe. Carbon allowances trade like most commodities, in the futures market, where [...] Read more at ETFtrends.com.

Financial markets rallied across the board in November, with the Core Equity Large Cap Equity category returning 5.5% for the second month in a row.

Amgen has agreed to buy Horizon Therapeutics in a deal valued at $27.8 billion. The Thousand Oak, California-based biopharmaceutical company announced on Monday that it will pay $116.50 in cash for each share of Horizon. Based in Dublin, Horizon develops potential treatments for rare, autoimmune, and inflammatory diseases. Horizon manufactures Tepezza, a thyroid eye disease [...] Read more at ETFtrends.com.

ETFs offering biotech exposure are rallying on Monday, lifted by a significant M&A announcement in the industry. The ALPS Medical Breakthroughs ETF (SBIO) increased by 1.8% in mid-day trading on Monday. During the same period, the SPDR S&P Biotech ETF (XBI) gained 2.4%, and the iShares Biotechnology ETF (IBB) is up 0.2%, according to YCharts. The healthcare sector is up today [...] Read more at ETFtrends.com.